Quantcast
Home / Opinion Digests / Business Law / Tumor Treatment Patent Rejected for ‘Obviousness’ (access required)

Tumor Treatment Patent Rejected for ‘Obviousness’ (access required)

In plaintiffs’ suit challenging the U.S. Patent and Trademark Office’s denial of his application for a patent relating to a method for treating tumors with formic acid, an Alexandria U.S. District Court grants summary judgment for the PTO’s rejection of plaintiffs’ application for lack of enablement and obviousness. This case presents three issues. Plaintiffs assign error ...

Print, Digital & Mobile

1 Month
$39

----------
6 Months
$199

----------
1 Year
$269

----------
2 Years
$659

----------
Digital & Mobile Only

1 Year
$299

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 

Scroll To Top